Edwards Pharmaceuticals, Inc.
11 drugs in NADAC|10 Generic,1 Brand
Edwards Pharmaceuticals, Inc. lists 11 NDCs in the CMS NADAC file (10 generic, 1 brand), at an average NADAC of $0.83 per unit, with a week-over-week move of -0.2% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
11
10G / 1B
Avg Price / Unit
$0.8330
$0.04 – $3.98
Avg 7d Change
-0.16%
Across 7 drugs with changes
7d Activity
of 11 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
METHENAMINE, SODIUM PHOSPHATE, MONOBASIC, METHYLENE BLUE, and HYOSCYAMINE SULFATE market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
alpha-1 Adrenergic Agonist therapeutic class
Review the broader class where Edwards Pharmaceuticals, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Edwards Pharmaceuticals, Inc. make?
Edwards Pharmaceuticals, Inc. lists 11 NDCs in the CMS NADAC file — 10 generic and 1 brand product.
What is the average price of Edwards Pharmaceuticals, Inc. drugs?
The average NADAC across Edwards Pharmaceuticals, Inc.'s portfolio is $0.8330 per unit, ranging from $0.0364 to $3.9761.
What types of drugs does Edwards Pharmaceuticals, Inc. make?
Edwards Pharmaceuticals, Inc. makes drugs across 7 FDA pharmacologic classes. The most common by NDC count are alpha-1 Adrenergic Agonist (8), Histamine-1 Receptor Antagonist (4), Sigma-1 Agonist (4), Uncompetitive N-methyl-D-aspartate Receptor Antagonist (4), Osmotic Laxative (2).
Has Edwards Pharmaceuticals, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Edwards Pharmaceuticals, Inc. in the openFDA feed.
How has Edwards Pharmaceuticals, Inc.'s pricing changed recently?
Over the past 7 days, 3 Edwards Pharmaceuticals, Inc. products rose and 4 fell, with a portfolio-wide average change of -0.2%.